TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04790058

Intervention type: OTHER
Intervention: Knowledge translation of the CSRS practice recommendations
Description: The intervention is knowledge translation of the CSRS practice recommendations; the application of the practice recommendations will occur during the patient's ED visit and patients who are eligible for 15-day cardiac rhythm monitoring will have Holter monitor applied at the time of ED discharge. For the secondary objective to validate the accuracy of the ultra-low risk criteria of CSRS and assess for potential improvements in the practice recommendations and the prediction models we will request verbal consent during the index ED visit for addition of cardiac biomarker measurements \[troponin and NT-proBNP\] for patients who did not have such measurements performed as part of routine clinical care, and a 30-day telephone follow-up for serious outcome assessment. Patients who do not consent will be excluded from these portions of the study but included in the health resource utilization and generic patient safety outcome assessment objectives.
Study: NCT06457633

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experiential FW
Description: Traditional Fibrowalk based on Pain Science Education (30 min.) - Cognitive restructuring (30 min.) - Mindfulness techniques (30 min.) - Physical exercise in a natural environment / nature exposure (30 min.) carried out experientially.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional FW
Description: Traditional Fibrowalk based on Pain Science Education (30 min.) - Cognitive restructuring (30 min.) - Mindfulness techniques (30 min.) - Physical exercise in a natural environment / nature exposure (30 min.)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online FW
Description: Traditional Fibrowalk based on Pain Science Education (30 min.) - Cognitive restructuring (30 min.) - Mindfulness techniques (30 min.) - Physical exercise in a natural environment / nature exposure (30 min.) performed virtually.
Study: NCT05129267

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group B
Description: Scaling and Root debridement + iPRF

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group C
Description: Scaling and Root debridement + iPRF together with vitamin C
Study: NCT04979455

Intervention type: OTHER
Intervention: Core temperature monitoring
Description: Core temperature will be monitored on the day of exercise

Intervention type: OTHER
Intervention: Core temperature monitoring
Description: Core temperature will be monitored on the day of exercise

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Questionnaires will be completed at baseline and on the day of exercise

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Questionnaires will be completed at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Heart rate monitoring
Description: Heart rate will be monitored on the day of exercise

Intervention type: OTHER
Intervention: Heart rate monitoring
Description: Heart rate will be monitored on the day of exercise

Intervention type: OTHER
Intervention: Urine collection
Description: Urine samples will be collected at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Urine collection
Description: Urine samples will be collected at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Sleep monitoring
Description: Sleep will be monitored at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Sleep monitoring
Description: Sleep will be monitored at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Blood collection
Description: Blood samples will be completed at baseline

Intervention type: OTHER
Intervention: Blood collection
Description: Blood samples will be completed at baseline

Intervention type: OTHER
Intervention: Saliva collection
Description: Saliva samples will be collected at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Saliva collection
Description: Saliva samples will be collected at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Throat swab collection
Description: Throat swab samples will be collected at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Throat swab collection
Description: Throat swab samples will be collected at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Stool collection
Description: Stool samples will be collected at baseline and on the day of exercise

Intervention type: OTHER
Intervention: Stool collection
Description: Stool samples will be collected at baseline and on the day of exercise
Study: NCT05070247

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-500
Description: TAK-500 intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab intravenous infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab intravenous infusion.
Study: NCT06573450

Intervention type: OTHER
Intervention: questionnaire survey
Description: subjects fill out questionnaires

Intervention type: OTHER
Intervention: questionnaire survey
Description: subjects fill out questionnaires

Intervention type: OTHER
Intervention: questionnaire survey
Description: subjects fill out questionnaires
Study: NCT06134856

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ankle mobilization
Description: Ankle joint mobilization as described in treatment arm description

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham treatment
Description: Light passive movement of the foot and ankle, avoiding the end-ranges which may actually elicit a mechanical change
Study: NCT05140967

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Description: High Intensity Interval Training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate Continuous Intensity Training (MICT)
Description: Moderate Intensity Continuous Training
Study: NCT06274073

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dorsal digital block
Description: Dorsal regional digital block anesthesia (No drug or device is being investigated here; the two digital block procedure mentioned are compared)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Palmar digital block
Description: Palmar regional digital block anesthesia (No drug or device is being investigated here; the two digital block procedures mentioned are compared)
Study: NCT06083961

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alirocumab
Description: Initial alirocumab, single dose of 300mg, subcutaneous injection
Study: NCT05180708

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: QTORIN 3.9% rapamycin anhydrous gel
Description: QTORIN 3.9% rapamycin anhydrous gel

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Matching vehicle (QTORIN anyhydrous gel)
Study: NCT05805995

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: vertebral derotation
Description: * Incentive spirometer (Mediciser): Used for breathing exercises.~* Cycle ergometer ( Mijnhardt , St. Paul, MN): Used for lower limb exercise.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: vertebral derotation
Description: * Incentive spirometer (Mediciser): Used for breathing exercises.~* Cycle ergometer ( Mijnhardt , St. Paul, MN): Used for lower limb exercise.
Study: NCT04257266

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ice Pack Cooling
Description: 5 ice packs (Cryo cooling pack or commercial ice pack) will be placed on the subject for 30 mins after exercise-induced hyperthermia

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ice Pack Cooling
Description: 5 ice packs (Cryo cooling pack or commercial ice pack) will be placed on the subject for 30 mins after exercise-induced hyperthermia
Study: NCT05507385

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IMAGINE-POSITIVE
Description: The intervention will combine aspects of Memory Specificity Training (MeST), which includes information about the links between memories and emotions, with Positive Prospective Mental Imagery (PPMI), to increase vividness and savouring of positive future images, in order to harness positive affect. IMAGINE-PA will follow a treatment manual and delivery will be accompanied by a therapy workbook.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Non-directive supportive therapy (NDST) consists of individual sessions, with an empathetic, emotionally supportive practitioner and provides non-directive problem solving and monitoring. Using NDST will control for factors that may contribute to change, which are not active components e.g. speaking to an empathetic therapist. NDST will follow treatment guidelines.
Study: NCT05385458

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT Intervention
Description: Acceptance and Commitment Therapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual Care Services
Study: NCT06339866

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Two Different Video Interventions on Pain and Anxiety in Children with Adenotonsillectomy: A Randomized Controlled Study
Description: The population of the study will be all patients who had adenotonsillectomy surgery between the ages of 6-12 in the Ear Nose and Throat Service of Zonguldak Bülent Ecevit University Hospital, and the sample will be all patients who had adenotonsillectomy surgery between the specified dates and who meet the inclusion criteria.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Two Different Video Interventions on Pain and Anxiety in Children with Adenotonsillectomy: A Randomized Controlled Study
Description: The population of the study will be all patients who had adenotonsillectomy surgery between the ages of 6-12 in the Ear Nose and Throat Service of Zonguldak Bülent Ecevit University Hospital, and the sample will be all patients who had adenotonsillectomy surgery between the specified dates and who meet the inclusion criteria.
Study: NCT06197646

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cartoon characters inhaler mask
Description: Cartoon characters inhaler mask
Study: NCT06469749

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Theory-based and peer-led intervention on Instagram
Description: A pilot randomized controlled trial of the 12-weeks social media intervention for non-medical use of prescription opioids (NMUPO) among young adults will be developed upon the formative research (Aim 1) grounded in the information-motivation-behavioral-skills (IMB) model. Intervention will be delivered by peer leaders, who are well-trained recovery coaches, via private groups on Instagram. Intervention contents will be tailored to psychosocial factors contributing to NMUPO.~Intervention components. Incorporating Instagram functions, the intervention is planned to include four intervention modules: (1) NMUPO knowledge module, (2) self-care module, (3) virtual goal setting/monitoring module, (4) peer support module. Intervention will be delivered by peer leaders (assisted by clinical psychology trainees a) via private groups operated by their Instagram accounts. The process will be overseen by certificated experts in clinical psychology and addiction treatment.
Study: NCT05995314

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO
Description: 3 mg/kg of cellulose (0 mg/kg of caffeine)

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 3 mg/kg of caffeine
Description: Ingestion of 3 mg/kg of body mass of caffeine

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 6 mg/kg of caffeine
Description: Ingestion of 6 mg/kg of body mass of caffeine
Study: NCT04684225

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand Therapy via Telerehabilitation
Description: Hand Therapy via Telerehabilitation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand Therapy via home-exercises
Description: Hand Therapy via home-exercises
Study: NCT04670133

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inulin
Description: Supplementation with a prebiotic, specifically inulin.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Supplementation with maltodextrin (placebo)
Study: NCT06398769

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SecuFix UM
Description: All surgeries were performed using Secufix UM.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VCare UM
Description: All surgeries were performed using VCare UM.
Study: NCT05987046

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contrast training
Description: Three sets of three repetitions of parallel squats at 90% of 1RM
Study: NCT04630197

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: e-CBT
Description: The description is provided in the treatment arm description.
Study: NCT05638152

Intervention type: OTHER
Intervention: implementation of a bundle of non-pharmacological interventions aimed at stress reduction
Description: The bundle consists of 4 interventions:~* natural imagery in the PACU (wall length decorations and lighted ceiling panels with sky views~* Aromatherapy with fragrances selected for anxiolytic and antiemetic properties~* Music available to patients~* Comfort Talk communication course for PACU nurses
Study: NCT06422117

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK16149 20mg-40mg BID
Description: Oral, 20mg, BID, adjustable to 40mg, BID based on tolerability and efficacy;

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, oral, 2 capsules twice daily
Study: NCT06395610

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF6001 DPI
Description: Single dose of CHF6001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF6001 DPI
Description: Single dose of CHF6001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythromycin
Description: Repeated doses of oral Erythromycin
Study: NCT05455905

Intervention type: DIAGNOSTIC_TEST
Intervention: Patient Health Questionnaire-9
Description: The Patient Health Questionnaire-9 is a nine question self-administered examination in which the patient indicates how often they have experienced different feelings and sensations in the past two weeks. The Patient Health Questionnaire-9 is scored from 0 to 27 where higher scores are associated with more severe depression.

Intervention type: DIAGNOSTIC_TEST
Intervention: Patient Health Questionnaire-9
Description: The Patient Health Questionnaire-9 is a nine question self-administered examination in which the patient indicates how often they have experienced different feelings and sensations in the past two weeks. The Patient Health Questionnaire-9 is scored from 0 to 27 where higher scores are associated with more severe depression.

Intervention type: DIAGNOSTIC_TEST
Intervention: Generalized Anxiety Disorder-7
Description: The Generalized Anxiety Disorder-7 is a seven question self-administered examination in which the patient indicates how often they have experienced different feelings and sensations in the past two weeks. The Generalized Anxiety Disorder-7 is scored from 0 to 21 where higher scores are associated with more severe anxiety.

Intervention type: DIAGNOSTIC_TEST
Intervention: Generalized Anxiety Disorder-7
Description: The Generalized Anxiety Disorder-7 is a seven question self-administered examination in which the patient indicates how often they have experienced different feelings and sensations in the past two weeks. The Generalized Anxiety Disorder-7 is scored from 0 to 21 where higher scores are associated with more severe anxiety.

Intervention type: DIAGNOSTIC_TEST
Intervention: Hamilton Depression Rating Scale
Description: The Hamilton Depression Rating Scale is administered by a mental health profession and includes twenty-one questions asking about how the participant has been feeling in the past week. The Hamilton Depression Rating Scale is scored from 0 to 45 where higher scores are associated with more severe depression.

Intervention type: DIAGNOSTIC_TEST
Intervention: Hamilton Anxiety Rating Scale
Description: The Hamilton Anxiety Rating Scale is administered by a mental health profession and includes fourteen questions asking about how the participant has been feeling in the past week. The Hamilton Anxiety Rating Scale is scored from 0 to 56 where higher scores are associated with more severe anxiety.
Study: NCT06181864

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NAO intervention
Description: The subjects will undergo a pre-intervention assessment phase that will consist of administering the Test of Emotional Vocabulary (TLE) and the Test of emotion comprehension (TEC). The tests will be re-submitted at the end of the intervention. Having ascertained the presence of the inclusion criteria and following randomization of the sample, the Experimental Group constituted of 20 children, will be administered the research task, which involves 15 sessions, one per week lasting one hour and thirty minutes. the children are guided by the voice of the robot Nao. The robot guides them in carrying out practical and relaxation activities. Consequently, audio visual feedback will be provided, via the robot, to return information to the subject about the accuracy of the response.

Intervention type: OTHER
Group type: OTHER
Intervention: Traditional intervention
Description: The subjects will undergo a pre-intervention assessment phase that will consist of administering the Test of Emotional Vocabulary (TLE) and the Test of emotion comprehension (TEC). The tests will be re-submitted at the end of the intervention. Having ascertained the presence of the inclusion criteria and following randomization of the sample, the Experimental Group constituted of 20 children, will be administered the research task, which involves 15 sessions, one per week lasting one hour and thirty minutes. The children are guided by the instructions of the operator who guides them in carrying out practical and relaxation activities. Consequently, the operator will provide feedback, to return information to the subject regarding the accuracy of the response.
Study: NCT05372770

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flourish Vaginal Care system
Description: Flourish includes Restore® vaginal moisturizing gel, a Class II medical device cleared by the FDA, in addition to two other kit components

Intervention type: DEVICE
Group type: OTHER
Intervention: Flourish Vaginal Care system
Description: Flourish includes Restore® vaginal moisturizing gel, a Class II medical device cleared by the FDA, in addition to two other kit components
Study: NCT05801731

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: The low GI snack is a biscuit with a Glycemic Index of 23.8 ± 3.3. The low GI snack contains plain flour, fibre, plant-based protein, vegetable oil and a low GI sweetener.~The interventional snacks (control, experimental) are matched for caloric content.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The normal GI snack is a biscuit with a Glycemic Index of 54.4 ± 6.3. The control snack is formulated using basic ingredients for a biscuit recipe consisting of all-purpose flour, butter, sugar, vanilla flavour, baking soda, egg and salt.
Study: NCT06132555

Intervention type: OTHER
Intervention: Online questionnaire survey
Description: The investigators have made an electronic questionnaire through the questionnaire star, and send the link or two-dimensional code of the electronic questionnaire to the subjects through WeChat or SMS to remind them to fill in the answer on the mobile phone or computer.~The questionnaire consisted of four parts: (1) basic information of the interviewees, (2) drug abuse of the interviewees, (3) drug treatment interventions received by the interviewees, and (4) problems encountered by the interviewees when they return to society.

Intervention type: OTHER
Intervention: In-depth personal interview
Description: The in-depth personal interview was conducted in a semi-structured way. The outline of the interview was formulated from seven aspects: drug use history, drug abstinence history, relapse situation, living conditions, physical and mental health status, return to society status, and active drug abstinence willingness of the drug abstinence personnel. The aim was to understand the needs of drug addicts in terms of family relationship, peer relationship, history of drug use, history of drug withdrawal, employment, economy, social support network, psychology, and assistance.

Intervention type: OTHER
Intervention: Colloquia
Description: The colloquia were carried out in the form of group interviews, 1-2 people from each different institution were selected to participate, and the number of people in each colloquium was controlled to be between 6 and 12.~The colloquia mainly focused on: ① The status quo of the implementation of the local drug drug treatment policy, ② the status quo of the compulsory isolation drug treatment work, ③ the status quo of the work of social workers for drug drug treatment, ④ the status quo of the work of community health centers, ⑤ the operation of various mechanisms in the work of various units, and ⑥ what content in the drug control work needs assistance from other departments and what external resources are needed.